What is Wearable Health's earnings per share (EPS)?

Wearable Health (WHSI) reported diluted earnings per share of $-0.00 for fiscal year 2023. This represents a 86.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Wearable Health Financials

WHSI

Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2023 Currency USD FYE June

This page shows Wearable Health (WHSI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI WHSI FY2023 2026-04-22

The business model looks less like a self-funding seller and more like an externally financed operation with shrinking gross profit support.

From FY2021 through FY2023, financing inflows of about $5.8M nearly matched cumulative free cash burn of $5.6M, so the company was kept going mainly by new capital rather than by sales. That reading fits the share count more than doubling over the same stretch while equity stayed deeply negative, which suggests new money has been replacing internally generated cash rather than supporting expansion from a cash-producing base.

The core sales engine has weakened: gross margin fell from 73.2% in FY2018 to 35.9% in FY2023 even as selling and administrative costs were reduced. Because overhead was not rising with the deterioration, the pressure appears to come more from weaker unit economics or revenue mix than from administrative sprawl.

FY2023 ended with a thin liquidity cushion: liabilities of $3.8M sat against only $223K of assets. Cash was just $136K, and a 0.04x current ratio means near-term obligations were far larger than near-term resources.

Financial Health Signals

Financial health score pending refresh

We are recalculating Wearable Health's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress

-312.36

Wearable Health scores -312.36, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($183K) relative to total liabilities ($3.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/7

Wearable Health passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.54x

For every $1 of reported earnings, Wearable Health generates $0.54 in operating cash flow (-$1.3M OCF vs -$2.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-212.4x

Wearable Health earns $-212.4 in operating income for every $1 of interest expense (-$2.3M vs $11K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$745K

YoY-28.8%

5Y CAGR-10.5%

10Y CAGR+5.1%

Wearable Health generated $745K in revenue in fiscal year 2023. This represents a decrease of 28.8% from the prior year.

EBITDA

-$2.3M

Wearable Health's EBITDA was -$2.3M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income

-$2.4M

Wearable Health reported -$2.4M in net income in fiscal year 2023.

EPS (Diluted)

$-0.00

YoY+86.7%

Wearable Health earned $-0.00 per diluted share (EPS) in fiscal year 2023. This represents an increase of 86.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$1.3M

YoY+59.2%

Wearable Health generated -$1.3M in free cash flow in fiscal year 2023, representing cash available after capex. This represents an increase of 59.2% from the prior year.

Cash & Debt

$136K

YoY+93.1%

5Y CAGR+5.1%

10Y CAGR+139.4%

Wearable Health held $136K in cash against $0 in long-term debt as of fiscal year 2023.

Dividends Per Share

N/A

Shares Outstanding

1.56B

YoY+4.6%

Wearable Health had 1.56B shares outstanding in fiscal year 2023. This represents an increase of 4.6% from the prior year.

Margins & Returns

Gross Margin

35.9%

YoY-9.7pp

5Y CAGR-33.5pp

10Y CAGR-26.8pp

Wearable Health's gross margin was 35.9% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is down 9.7 percentage points from the prior year.

Operating Margin

-307.9%

10Y CAGR-8.2pp

Wearable Health's operating margin was -307.9% in fiscal year 2023, reflecting core business profitability.

Net Margin

-320.6%

5Y CAGR-260.3pp

10Y CAGR-230.6pp

Wearable Health's net profit margin was -320.6% in fiscal year 2023, showing the share of revenue converted to profit.

Return on Equity

N/A

Capital Allocation

R&D Spending

$50K

YoY-87.3%

5Y CAGR+8.9%

Wearable Health invested $50K in research and development in fiscal year 2023. This represents a decrease of 87.3% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$9K

YoY-81.1%

Wearable Health invested $9K in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents a decrease of 81.1% from the prior year.

WHSI Income Statement

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Revenue	$745K-28.8%	$1.0M-25.0%	$1.4M+81.0%	$770K-21.1%	$976K-24.7%	$1.3M
Cost of Revenue	$477K-16.0%	$568K-34.6%	$869K+118.4%	$398K+52.3%	$261K-33.9%	$396K
Gross Profit	$268K-43.9%	$477K-9.0%	$525K+41.0%	$372K-47.9%	$715K-20.6%	$900K
R&D Expenses	$50K-87.3%	$391K	$0	$0	$0-100.0%	$32K
SG&A Expenses	$348K-14.9%	$409K-42.8%	$716K-8.4%	$781K-15.5%	$924K-32.7%	$1.4M
Operating Income	-$2.3M	N/A	-$3.2M-627.4%	-$435K-77.9%	-$244K	N/A
Interest Expense	$11K-12.0%	$12K-94.5%	$221K-21.2%	$281K+716.9%	$34K-78.1%	$157K
Income Tax	$0	$0	$0	$0	$0	N/A
Net Income	-$2.4M	N/A	-$3.3M-363.1%	-$715K-156.7%	-$279K+64.3%	-$780K
EPS (Diluted)	$-0.00+86.7%	$-0.01-90.5%	$-0.01	N/A	N/A	N/A

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Revenue	$127K-10.6%	$142K+4.1%	$137K-29.4%	$194K-2.2%	$198K-8.5%	$216K-4.0%	$226K+5.9%	$213K
Cost of Revenue	$83K+66.1%	$50K-59.2%	$123K-9.2%	$135K+36.0%	$99K-17.2%	$120K+8.8%	$110K-1.0%	$111K
Gross Profit	$44K-52.3%	$92K+557.0%	$14K-76.0%	$59K-40.6%	$99K+2.2%	$96K-16.3%	$115K+13.4%	$102K
R&D Expenses	$0-100.0%	$15K-68.0%	$48K	$0	$0-100.0%	$2K+105.6%	-$39K-118.7%	$210K
SG&A Expenses	$29K-63.9%	$80K-21.9%	$102K+22.4%	$84K+3.9%	$80K-1.9%	$82K-52.0%	$171K+91.7%	$89K
Operating Income	-$72K+78.6%	-$336K+37.3%	-$535K-11.6%	-$480K+7.7%	-$519K+31.7%	-$760K	N/A	N/A
Interest Expense	N/A	$3K+480.0%	$591-82.4%	$3K-2.2%	$3K0.0%	$3K+106.2%	-$56K-756.2%	$8K
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$125K+562.5%	$19K+103.3%	-$578K-10.7%	-$522K+3.3%	-$540K+27.9%	-$749K	N/A	N/A
EPS (Diluted)	$0.00	$0.00	N/A	$-0.00	$0.00	$0.00	N/A	$-0.01

WHSI Balance Sheet

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Total Assets	$223K-34.2%	$339K-62.7%	$908K+666.1%	$119K-48.5%	$230K-59.7%	$571K
Current Assets	$152K-48.8%	$297K-67.2%	$908K+707.8%	$112K-48.1%	$216K-58.5%	$521K
Cash & Equivalents	$136K+93.1%	$71K-91.7%	$847K+22037.7%	$4K-15.3%	$5K-95.8%	$106K
Inventory	$9K+21.1%	$7K	$0-100.0%	$5K-94.2%	$91K+1114.7%	$8K
Accounts Receivable	$379	$0-100.0%	$26K+109.1%	$12K-84.1%	$77K-0.7%	$78K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.8M+56.3%	$2.4M-42.9%	$4.3M+83.2%	$2.3M+32.8%	$1.7M+3.5%	$1.7M
Current Liabilities	$3.8M+55.5%	$2.4M-42.9%	$4.3M+121.1%	$1.9M+10.1%	$1.7M+35.3%	$1.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.6M-71.0%	-$2.1M+37.6%	-$3.4M-51.9%	-$2.2M-45.1%	-$1.5M-35.7%	-$1.1M
Retained Earnings	-$41.8M-6.1%	-$39.4M-49.5%	-$26.4M-39.4%	-$18.9M-3.9%	-$18.2M-28.3%	-$14.2M

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Total Assets	$90K-28.5%	$125K-43.8%	$223K+71.8%	$130K-37.8%	$209K-51.0%	$426K+25.7%	$339K-46.4%	$632K
Current Assets	$32K-47.3%	$61K-59.8%	$152K+190.5%	$52K-58.0%	$125K-62.8%	$336K+12.8%	$297K-49.4%	$588K
Cash & Equivalents	$410-96.2%	$11K-92.2%	$136K+733.2%	$16K-64.1%	$45K-82.2%	$256K+263.0%	$71K-87.6%	$570K
Inventory	$5K-40.2%	$9K0.0%	$9K-74.3%	$33K-48.1%	$64K+55.8%	$41K+483.2%	$7K	$0
Accounts Receivable	$27K+93.1%	$14K+3546.4%	$379-53.3%	$812-91.2%	$9K-44.7%	$17K	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.2M-10.8%	$3.6M-6.1%	$3.8M+25.5%	$3.0M+12.8%	$2.7M+9.1%	$2.5M+1.2%	$2.4M-2.2%	$2.5M
Current Liabilities	$3.2M-10.7%	$3.6M-6.1%	$3.8M+25.8%	$3.0M+17.7%	$2.6M+5.1%	$2.4M0.0%	$2.4M-2.2%	$2.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.1M+10.2%	-$3.4M+3.8%	-$3.6M-23.4%	-$2.9M-17.1%	-$2.5M-21.7%	-$2.0M+2.8%	-$2.1M-12.9%	-$1.9M
Retained Earnings	-$41.7M+0.3%	-$41.8M0.0%	-$41.8M-1.4%	-$41.2M-1.3%	-$40.7M-1.3%	-$40.2M-1.9%	-$39.4M-2.5%	-$38.5M

WHSI Cash Flow Statement

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Operating Cash Flow	-$1.3M+58.8%	-$3.1M-164.8%	-$1.2M-786.2%	-$132K-26.5%	-$105K	N/A
Capital Expenditures	$9K-81.1%	$50K	$0	$0	$0	N/A
Free Cash Flow	-$1.3M+59.2%	-$3.2M-169.1%	-$1.2M-786.2%	-$132K-26.5%	-$105K	N/A
Investing Cash Flow	-$9K+81.1%	-$50K	$0	$0	$0	N/A
Financing Cash Flow	$1.4M-43.1%	$2.4M+17.8%	$2.0M+1434.3%	$132K+67.7%	$79K-91.6%	$933K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Operating Cash Flow	-$10K+94.1%	-$175K-48.7%	-$117K-10.6%	-$106K+78.5%	-$495K+11.8%	-$561K-28.7%	-$436K+49.6%	-$864K
Capital Expenditures	$0	$0	$0	$0	$0-100.0%	$9K	$0	$0
Free Cash Flow	-$10K+94.1%	-$175K-48.7%	-$117K-10.6%	-$106K+78.5%	-$495K+13.3%	-$571K-30.9%	-$436K+49.6%	-$864K
Investing Cash Flow	$0	$0	$0	$0	$0+100.0%	-$9K	$0	$0
Financing Cash Flow	$0-100.0%	$49K-79.3%	$237K+207.9%	$77K-72.9%	$284K-62.4%	$756K+1291.8%	-$63K+61.7%	-$166K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

WHSI Financial Ratios

Metric	FY23	FY22	FY21	FY19	FY18	FY16
Gross Margin	35.9%-9.7pp	45.6%+8.0pp	37.6%-10.7pp	48.3%-24.9pp	73.2%+3.8pp	69.4%
Operating Margin	-307.9%	N/A	-226.8%-170.4pp	-56.4%-31.4pp	-25.0%	N/A
Net Margin	-320.6%	N/A	-237.6%-144.8pp	-92.9%-64.3pp	-28.6%+31.7pp	-60.2%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-1070.2%	N/A	-365.0%+238.8pp	-603.8%-482.6pp	-121.2%+15.5pp	-136.7%
Current Ratio	0.04-0.1	0.12-0.1	0.21+0.2	0.06-0.1	0.12-0.3	0.40
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	-173.0%+128.9pp	-301.9%-217.7pp	-84.2%-67.0pp	-17.2%-6.5pp	-10.7%	N/A

Metric	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22
Gross Margin	34.6%-30.2pp	64.8%+54.5pp	10.3%-19.9pp	30.2%-19.6pp	49.8%+5.2pp	44.6%-6.5pp	51.1%+3.4pp	47.7%
Operating Margin	-56.3%+179.4pp	-235.8%+155.2pp	-391.0%-143.4pp	-247.6%+14.7pp	-262.3%+88.8pp	-351.1%	N/A	N/A
Net Margin	98.4%+85.1pp	13.3%+435.5pp	-422.2%-152.7pp	-269.5%+3.1pp	-272.6%+73.3pp	-345.9%	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	139.8%+124.7pp	15.1%+274.0pp	-258.9%+143.0pp	-401.9%-143.4pp	-258.5%-82.8pp	-175.7%	N/A	N/A
Current Ratio	0.010.0	0.02-0.0	0.04+0.0	0.02-0.0	0.05-0.1	0.14+0.0	0.12-0.1	0.24
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	-8.1%+114.6pp	-122.7%-36.8pp	-85.9%-31.1pp	-54.8%+195.0pp	-249.8%+13.8pp	-263.6%-70.2pp	-193.3%+212.5pp	-405.8%

Note: Shareholder equity is negative (-$3.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Hear Atlast Holdings HRAL

$222K

Innerscope Hear INND

$39K

Cecors Inc CEOS

$2.2M

Cardiac Biotech Solutions Inc CBSC

$5.0M

United Health Pr UEEC

$10.4M

Frequently Asked Questions

What is Wearable Health's annual revenue?

Wearable Health (WHSI) reported $745K in total revenue for fiscal year 2023. This represents a -28.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Wearable Health's revenue growing?

Wearable Health (WHSI) revenue declined by 28.8% year-over-year, from $1.0M to $745K in fiscal year 2023.

Is Wearable Health profitable?

No, Wearable Health (WHSI) reported a net income of -$2.4M in fiscal year 2023, with a net profit margin of -320.6%.

What is Wearable Health's EBITDA?

Wearable Health (WHSI) had EBITDA of -$2.3M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

What is Wearable Health's gross margin?

Wearable Health (WHSI) had a gross margin of 35.9% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is Wearable Health's operating margin?

Wearable Health (WHSI) had an operating margin of -307.9% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

What is Wearable Health's net profit margin?

Wearable Health (WHSI) had a net profit margin of -320.6% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.

What is Wearable Health's free cash flow?

Wearable Health (WHSI) generated -$1.3M in free cash flow during fiscal year 2023. This represents a 59.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Wearable Health's operating cash flow?

Wearable Health (WHSI) generated -$1.3M in operating cash flow during fiscal year 2023, representing cash generated from core business activities.

What are Wearable Health's total assets?

Wearable Health (WHSI) had $223K in total assets as of fiscal year 2023, including both current and long-term assets.

What are Wearable Health's capital expenditures?

Wearable Health (WHSI) invested $9K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How much does Wearable Health spend on research and development?

Wearable Health (WHSI) invested $50K in research and development during fiscal year 2023.

How many shares does Wearable Health have outstanding?

Wearable Health (WHSI) had 1.56B shares outstanding as of fiscal year 2023.

What is Wearable Health's current ratio?

Wearable Health (WHSI) had a current ratio of 0.04 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.

What is Wearable Health's return on assets (ROA)?

Wearable Health (WHSI) had a return on assets of -1070.2% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is Wearable Health's cash runway?

Based on fiscal year 2023 data, Wearable Health (WHSI) had $136K in cash against an annual operating cash burn of $1.3M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Wearable Health's debt-to-equity ratio negative or not reported?

Wearable Health (WHSI) has negative shareholder equity of -$3.6M as of fiscal year 2023, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Wearable Health's Altman Z-Score?

Wearable Health (WHSI) has an Altman Z-Score of -312.36, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Wearable Health's Piotroski F-Score?

Wearable Health (WHSI) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Wearable Health's earnings high quality?

Wearable Health (WHSI) has an earnings quality ratio of 0.54x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Wearable Health cover its interest payments?

Wearable Health (WHSI) has an interest coverage ratio of -212.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.